This content is Free Access.
1Department of Speech-Language Pathology,University of Toronto, 2ALS/ MN Clinic,Sunnybrook Health Science Centre, 3Department of Special Education and Communication Disorders,University of Nebraska-Lincoln, 4Department of Neurology, Munroe-Meyer Institute,University of Nebraska Medical Center, 5Department of Neurology,University of Toronto
Chapters
- 00:05Title
- 00:55Introduction
- 02:19Respiratory Subsystem
- 05:05Phonatory Subsystem
- 06:23Resonatory Subsystem
- 07:10Articulatory Subsystem: Face
- 08:10Articulatory Subsystem: Tongue
- 09:22System-level Assessment
- 09:58Comprehensive Analyses of Bulbar Dysfunction in ALS
- 10:05Case Study: Healthy Talkers vs. a Talker with ALS
Objective assessments of the physiological mechanisms that support speech are needed to monitor disease onset and progression in persons with ALS and to quantify treatment effects in clinical trials. In this video, we present a comprehensive, instrumentation-based protocol for quantifying speech motor performance in clinical populations.
Tags
Bulbar DysfunctionAmyotrophic Lateral Sclerosis (ALS)AssessmentDiagnosisDisease ProgressionSpeech SubsystemsOutcome MeasuresExperimental Treatment TrialsInstrumental ApproachesObjective MeasuresRespiratoryPhonatoryResonatoryArticulatory SubsystemsFacial ComponentsTongueNeurological DiseasesSpeech PerformanceSpeaking RateIntelligibility Of Speech
